Ultrasound to guide treatment in chronic inflammatory neuropathy
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study uses ultrasound to see how nerve inflammation changes over time in people with a chronic nerve disease called CIDP. It may help doctors choose the best treatment. The trial includes both newly diagnosed patients and those whose current treatment isn't working well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have a confirmed diagnosis of CIDP (a chronic nerve inflammation disorder) — but not the sensory-only type
- You are either newly diagnosed and about to start IVIg treatment, or you have had CIDP for a while and your current treatment isn't controlling symptoms well enough
- You can have nerve tests, blood draws, and an ultrasound of your nerves
- You do not have other conditions that could cause similar nerve problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called rituximab to see if it can help people with chronic inflammatory demyelinating polyneuropathy (CIDP) achieve remission. It may offer a new treatment option for those who are newly diagnosed or who are on maintenance therapy with wear-off symptoms or failed withdrawal attempts.
This study tests if ultrasound can find nerve problems in people with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP), and if it helps doctors diagnose and predict outcomes early.
This study looks at how well current treatments work for people with CIDP (a nerve condition causing weakness). It tracks symptoms and daily function over time to help doctors understand which treatments may work best.
This trial tests a new antibody drug called obinutuzumab β for people with a long-term nerve condition called CIDP. It aims to see if the drug can help reduce symptoms and improve daily function.
This trial tests nipocalimab (an antibody medicine) to improve symptoms and control activity in chronic inflammatory demyelinating polyneuropathy (CIDP), a nerve disease that causes weakness and numbness. It may help reduce disease activity and disability, while checking safety.
This study uses ultrasound to look at nerves in people with a nerve condition called polyneuropathy that isn't caused by something else. It aims to see if ultrasound can help doctors diagnose this condition better.
Hear when a new CIDP trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.